Soleno Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Soleno Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About SLNO
Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder.
CEOAnish Bhatnagar
CEOAnish Bhatnagar
Employees92
Employees92
HeadquartersRedwood City, California
HeadquartersRedwood City, California
Founded1999
Founded1999
Employees92
Employees92
SLNO Key Statistics
Market cap2.83B
Market cap2.83B
Price-Earnings ratio-28.60
Price-Earnings ratio-28.60
Dividend yield—
Dividend yield—
Average volume1.60M
Average volume1.60M
High today$53.10
High today$53.10
Low today$49.51
Low today$49.51
Open price$50.06
Open price$50.06
Volume1.11M
Volume1.11M
52 Week high$90.32
52 Week high$90.32
52 Week low$41.50
52 Week low$41.50
Stock Snapshot
As of today, Soleno Therapeutics(SLNO) shares are valued at $52.58. The company's market cap stands at 2.83B, with a P/E ratio of -28.60.
As of 2025-12-05, Soleno Therapeutics(SLNO) stock has fluctuated between $49.51 and $53.10. The current price stands at $52.58, placing the stock +6.2% above today's low and -1.0% off the high.
Soleno Therapeutics(SLNO) shares are trading with a volume of 1.11M, against a daily average of 1.6M.
In the last year, Soleno Therapeutics(SLNO) shares hit a 52-week high of $90.32 and a 52-week low of $41.50.
In the last year, Soleno Therapeutics(SLNO) shares hit a 52-week high of $90.32 and a 52-week low of $41.50.
Analyst ratings
100%
of 13 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SLNO. This list is generated using Robinhood data, and it’s not a recommendation.